Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
申请公布号
WO2010123960(A2)
申请公布日期
2010.10.28
申请号
WO2010US31833
申请日期
2010.04.21
申请人
AXIKIN PHARMACEUTICALS, INC.;LY, TAI, WEI;FORRESTER, JARED, ANDREW
